Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Director dealing & appointment

29 May 2012 16:54

RNS Number : 3543E
BrainJuicer Group PLC
29 May 2012
 



 

 

 

 

Press Release

 29 May 2012

 

 

BrainJuicer Group PLC

 ("BrainJuicer" and the "Company")

 

Director Appointment and Director Dealing

 

BrainJuicer (AIM: BJU), a leading international online market research agency, announced on 23rd April 2012 that Simon Godfrey, a non-executive director of the Company, intends to retire from the board of directors by the end of September 2012.

 

He has been reducing his shareholding as a result, and the Company updates that Simon has today disposed of 10,000 shares at 308.50p per share. Following the above transaction, Simon currently holds 14,298 shares representing 0.1% of the voting rights of the Company.

 

As a replacement for Simon, the Board is appointing Graham Blashill (aged 65) as a non-executive director with effect from 1st July 2012. Graham has had a long career in sales and marketing of fast moving consumer goods. He joined W.D.& H.O. Wills (a division of Imperial Tobacco) in 1968, holding a number of marketing and trading roles, and becoming Managing Director Imperial Tobacco UK in 1995. In 2003 he was Regional Director for Western Europe, and in 2005 appointed Group Sales and Marketing Director responsible for Imperial Tobacco's global trading operations in over 160 countries. He served as a main board director of Imperial Tobacco Group plc, a leading FTSE 100 company, for six years before retiring in 2011.

 

Disclosures regarding Mr Blashill appointment, pursuant to AIM rules (Schedule 2 paragraph (g)), are set out below:

 

Directorships held within the last five years

 

·; Imperial Tobacco Group Plc

·; Imperial Tobacco Limited

·; Imperial Tobacco Overseas Holdings (3) Limited

·; Imperial Tobacco International Limited

·; Altadis S.A.U.

·; Skruf Snus AB

·; Societe Nationale D'explotation Industrielle Des Tabacs et Allumettes SAS (SEITA)

·; Imperial Tobacco Pension Trustees Limited

·; Tobacco Trade Benevolent Association

 

Current Directorships

 

·; Tobacco Pipe Makers and Tobacco Trade Benevolent Fund

 

There is no further information to be disclosed under AIM rules (Schedule 2 paragraph (g)) in respect of Mr Blashill's appointment.

 

The Company can be found at www.brainjuicer.com.

 

- Ends -

 

For further information, please contact:

BrainJuicer Group PLC

 

John Kearon, Chief Executive Officer

Tel: +44 (0)20 7043 1000

 

James Geddes, Chief Financial Officer

www.brainjuicer.com

 

Canaccord Genuity Limited

Simon Bridges / Henry Fitzgerald-O'Connor

Tel: +44 (0)20 7523 8000

www.canaccordgenuity.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGZKKLFGZZM
Date   Source Headline
1st May 20264:30 pmRNSHolding(s) in Company
21st Apr 20267:01 amRNSRelationship Agreement with Brave Bison
21st Apr 20267:00 amRNSQ4 and Full Year Trading Update
9th Apr 20267:00 amRNS-RLaunch of next evolution of Test Your Ad platform
30th Mar 20264:30 pmRNSHolding(s) in Company
30th Mar 20263:30 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTrading Update
16th Mar 20267:00 amRNSTrading Update
5th Mar 20263:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:15 pmRNSHolding(s) in Company
3rd Mar 20264:06 pmRNSBoard Change
2nd Mar 20261:39 pmRNSShareholder update & PDMR Dealing
2nd Mar 20267:00 amRNSDirectorate change
30th Jan 20261:00 pmRNSBoard Committee and Change of Role Update
20th Jan 20267:00 amRNSTrading Update
12th Jan 20264:45 pmRNSAppointment of Joint Corporate Broker
2nd Dec 20257:00 amRNSInterim Results
20th Nov 202511:45 amRNSHolding(s) in Company
24th Oct 20253:28 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSTrading Update
14th Oct 20259:16 amRNSCapital Markets Day
6th Oct 20253:30 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSDirector/PDMR Shareholding - replacement
29th Sep 20255:48 pmRNSDirector/PDMR Shareholding
29th Sep 20251:27 pmRNSHolding(s) in Company
26th Sep 20252:29 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
24th Sep 20253:01 pmRNSResult of AGM
23rd Sep 20257:00 amRNSTrading Update
15th Sep 20251:00 pmRNSDirector/PDMR Shareholding
27th Aug 20254:51 pmRNSNotice of AGM
8th Aug 20254:35 pmRNSDirector/PDMR Shareholding
9th Jul 20257:00 amRNSDirector Role Change
9th Jul 20257:00 amRNSFinal Results
9th Jul 20257:00 amRNSTrading Update
4th Jul 202511:45 amRNSHolding(s) in Company
4th Jul 20257:00 amRNSHolding(s) in Company
16th Jun 20251:30 pmRNSHolding(s) in Company
14th May 20257:00 amRNSEstablishment of New Long-Term Incentive Plan
24th Apr 20251:53 pmRNSHolding(s) in Company
23rd Apr 20257:00 amRNSTrading Statement
23rd Jan 20257:00 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Update
8th Jan 202510:15 amRNSHolding(s) in Company
3rd Dec 20247:00 amRNSInterim Results
28th Nov 20247:00 amRNSInterim Results Presentation
21st Nov 20243:31 pmRNSHolding(s) in Company
28th Oct 202410:15 amRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.